Sign In to Follow Application
View All Documents & Correspondence

Novel Indazole Derivative Or Salt Thereof Manufacturing Intermediate Therefor Antioxidant Using Same And Use For An Indazole Derivative Or Salt Thereof

Abstract: Disclosed are: the compound represented by formula (1) or a salt thereof; and a manufacturing intermediate therefor. Said compound exhibits excellent antioxidant activity in a microsomal lipid peroxidation measurement system using rat liver microsomes. Said compound or a salt thereof is useful as an antioxidant. Also disclosed is a use for the compound represented by formula (1) or a pharmacologically permitted salt thereof for manufacturing an antioxidant.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
21 December 2012
Publication Number
51/2014
Publication Type
INA
Invention Field
PHARMACEUTICALS
Status
Email
knk@kankrishme.com
Parent Application

Applicants

UBE INDUSTRIES LTD.
1978 96 Oaza Kogushi Ube shi Yamaguchi 7558633

Inventors

1. HAGIHARA Masahiko
c/o UBE INDUSTRIES LTD. 1978 96 Oaza Kogushi Ube shi Yamaguchi 7558633
2. KOMORI Ken ichi
c/o UBE INDUSTRIES LTD. 1978 96 Oaza Kogushi Ube shi Yamaguchi 7558633
3. SUNAMOTO Hidetoshi
c/o UBE INDUSTRIES LTD. 1978 96 Oaza Kogushi Ube shi Yamaguchi 7558633
4. NISHIDA Hiroshi
c/o UBE INDUSTRIES LTD. 1978 96 Oaza Kogushi Ube shi Yamaguchi 7558633
5. TSUZAKI Yasunori
c/o UBE INDUSTRIES LTD. 1978 96 Oaza Kogushi Ube shi Yamaguchi 7558633
6. TAKAMA Akira
c/o UBE INDUSTRIES LTD. 1978 96 Oaza Kogushi Ube shi Yamaguchi 7558633
7. KIDO Kazutaka
c/o SANTEN PHARMACEUTICAL CO. LTD. 9 19 Shimoshinjo 3 chome Higashiyodogawa ku Osaka shi Osaka 5338651
8. FUJIMOTO Tomokazu
c/o SANTEN PHARMACEUTICAL CO. LTD. 9 19 Shimoshinjo 3 chome Higashiyodogawa ku Osaka shi Osaka 5338651
9. MATSUGI Takeshi
c/o SANTEN PHARMACEUTICAL CO. LTD. 9 19 Shimoshinjo 3 chome Higashiyodogawa ku Osaka shi Osaka 5338651

Specification

Documents

Application Documents

# Name Date
1 10692-CHENP-2012-AbandonedLetter.pdf 2018-07-18
1 Form-5.pdf 2012-12-27
2 10692-CHENP-2012-FER.pdf 2018-01-10
2 Form 3.pdf 2012-12-27
3 Complete Specification.pdf 2012-12-27
3 10692-CHENP-2012-Form1.pdf 2017-03-07
4 abstract10692-CHENP-2012.jpg 2014-04-21
4 304.pdf 2012-12-27
5 10692-CHENP-2012.pdf 2013-01-08
5 10692-CHENP-2012 CORRESPONDENCE OTHERS 17-02-2014.pdf 2014-02-17
6 10692-CHENP-2012 POWER OF ATTORNEY 17-02-2014.pdf 2014-02-17
6 10692-CHENP-2012 FORM-3 16-05-2013.pdf 2013-05-16
7 Form-18(Online).pdf 2014-02-17
7 10692-CHENP-2012 CORRESPONDENCE OTHERS 16-05-2013.pdf 2013-05-16
8 10692-CHENP-2012 CORRESPONDENCE OTHERS 21-06-2013.pdf 2013-06-21
8 10692-CHENP-2012 FORM-13 21-06-2013.pdf 2013-06-21
9 10692-CHENP-2012 FORM-1 21-06-2013.pdf 2013-06-21
10 10692-CHENP-2012 FORM-13 21-06-2013.pdf 2013-06-21
10 10692-CHENP-2012 CORRESPONDENCE OTHERS 21-06-2013.pdf 2013-06-21
11 Form-18(Online).pdf 2014-02-17
11 10692-CHENP-2012 CORRESPONDENCE OTHERS 16-05-2013.pdf 2013-05-16
12 10692-CHENP-2012 POWER OF ATTORNEY 17-02-2014.pdf 2014-02-17
12 10692-CHENP-2012 FORM-3 16-05-2013.pdf 2013-05-16
13 10692-CHENP-2012.pdf 2013-01-08
13 10692-CHENP-2012 CORRESPONDENCE OTHERS 17-02-2014.pdf 2014-02-17
14 abstract10692-CHENP-2012.jpg 2014-04-21
14 304.pdf 2012-12-27
15 Complete Specification.pdf 2012-12-27
15 10692-CHENP-2012-Form1.pdf 2017-03-07
16 Form 3.pdf 2012-12-27
16 10692-CHENP-2012-FER.pdf 2018-01-10
17 Form-5.pdf 2012-12-27
17 10692-CHENP-2012-AbandonedLetter.pdf 2018-07-18

Search Strategy

1 10692CHENP2012-search_07-12-2017.pdf
1 STN-str1_07-12-2017.pdf
2 10692CHENP2012-search_07-12-2017.pdf
2 STN-str1_07-12-2017.pdf